MODERNA INC

NASDAQ: MRNA (Moderna, Inc.)

Kemas kini terakhir: 3 jam lalu

56.69

1.71 (3.10%)

Penutupan Terdahulu 54.98
Buka 55.00
Jumlah Dagangan 2,149,418
Purata Dagangan (3B) 12,090,222
Modal Pasaran 22,387,142,656
Harga / Jualan (P/S) 11.13
Harga / Buku (P/B) 2.51
Julat 52 Minggu
22.28 (-60%) — 59.55 (5%)
Tarikh Pendapatan 30 Apr 2026
Margin Keuntungan -105.67%
Margin Operasi (TTM) -972.22%
EPS Cair (TTM) -8.73
Pertumbuhan Hasil Suku Tahunan (YOY) -35.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 7.40%
Nisbah Semasa (MRQ) 4.22
Aliran Tunai Operasi (OCF TTM) -3.05 B
Aliran Tunai Bebas Leveraj (LFCF TTM) -3.20 B
Pulangan Atas Aset (ROA TTM) -15.84%
Pulangan Atas Ekuiti (ROE TTM) -29.34%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Biotechnology (US) Menaik Bercampur
Biotechnology (Global) Menaik Bercampur
Stok Moderna, Inc. Menaik Menurun

AISkor Stockmoo

-1.7
Konsensus Penganalisis -1.5
Aktiviti Orang Dalam -5.0
Volatiliti Harga -5.0
Purata Bergerak Teknikal -1.0
Osilator Teknikal 4.0
Purata -1.70

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
MRNA 22 B - - 2.51
COGT 6 B - - 10.99
GLTO 2 B - - 268.22
QURE 1 B - - 5.74
KALV 932 M - - 48.09
CGEM 881 M - - 2.06

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Sektor Healthcare
Industri Biotechnology
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 7.28%
% Dimiliki oleh Institusi 73.67%

Pemilikan

Nama Tarikh Syer Dipegang
Theleme Partners Llp 31 Dec 2025 8,081,810
Julat 52 Minggu
22.28 (-60%) — 59.55 (5%)
Julat Harga Sasaran
28.00 (-50%) — 69.00 (21%)
Tinggi 69.00 (Piper Sandler, 21.73%) Beli
Median 34.00 (-40.02%)
Rendah 28.00 (Morgan Stanley, -50.60%) Pegang
Purata 38.14 (-32.72%)
Jumlah 1 Beli, 6 Pegang
Harga Purata @ Panggilan 39.56
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Piper Sandler 23 Feb 2026 69.00 (21.73%) Beli 50.29
Evercore ISI Group 17 Feb 2026 35.00 (-38.26%) Pegang 43.93
Goldman Sachs 17 Feb 2026 41.00 (-27.67%) Pegang 43.93
RBC Capital 17 Feb 2026 30.00 (-47.08%) Pegang 43.93
UBS 07 Jan 2026 34.00 (-40.02%) Pegang 35.89
Jefferies 12 Dec 2025 30.00 (-47.08%) Pegang 29.46
Morgan Stanley 12 Dec 2025 28.00 (-50.60%) Pegang 29.46
Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
HOGE STEPHEN - 53.57 -19,260 -1,031,758
KLINGER SHANNON THYME - 53.42 -24,426 -1,299,917
MOCK JAMES M - 53.70 -11,027 -592,199
Jumlah Keseluruhan Kuantiti Bersih -54,713
Jumlah Keseluruhan Nilai Bersih ($) -2,923,875
Purata Pembelian Keseluruhan ($) -
Purata Jualan Keseluruhan ($) 53.54
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
MOCK JAMES M Pegawai 05 Mar 2026 Dibuang (-) 5,704 53.83 307,046
MOCK JAMES M Pegawai 05 Mar 2026 Pelaksanaan pilihan 11,797 - -
KLINGER SHANNON THYME Pegawai 05 Mar 2026 Dibuang (-) 5,704 53.83 307,046
KLINGER SHANNON THYME Pegawai 05 Mar 2026 Pelaksanaan pilihan 11,797 - -
KLINGER SHANNON THYME Pegawai 02 Mar 2026 Jual automatik (-) 13,885 52.85 733,753
KLINGER SHANNON THYME Pegawai 02 Mar 2026 Pelaksanaan pilihan 13,885 - -
MOCK JAMES M Pegawai 27 Feb 2026 Dibuang (-) 5,323 53.57 285,153
MOCK JAMES M Pegawai 27 Feb 2026 Pelaksanaan pilihan 11,004 - -
KLINGER SHANNON THYME Pegawai 27 Feb 2026 Dibuang (-) 4,837 53.57 259,118
KLINGER SHANNON THYME Pegawai 27 Feb 2026 Pelaksanaan pilihan 9,999 - -
HOGE STEPHEN Pegawai 27 Feb 2026 Dibuang (-) 19,260 53.57 1,031,758
HOGE STEPHEN Pegawai 27 Feb 2026 Pelaksanaan pilihan 39,830 - -
Papar semua
Tarikh Jenis Butiran
06 Mar 2026 CNBC FDA reversals leave investors worrying about the fates of other experimental drugs
11 Feb 2026 CNBC Moderna says FDA refuses to review its application for experimental flu shot
04 Feb 2026 Pengumuman Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc.
30 Jan 2026 Pengumuman Dr. David Berman to Join Moderna as Chief Development Officer
29 Jan 2026 Pengumuman Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
27 Jan 2026 Pengumuman Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
26 Jan 2026 Pengumuman Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
20 Jan 2026 Pengumuman Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Follow...
12 Jan 2026 Pengumuman Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
05 Jan 2026 Pengumuman Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
18 Dec 2025 Pengumuman CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
17 Dec 2025 Pengumuman Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
15 Dec 2025 Pengumuman EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda